

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | signal peptide processing (GO:0006465) | 7.01015117 |
| 2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.71226271 |
| 3 | negative regulation of glucose import (GO:0046325) | 6.52916676 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.34740389 |
| 5 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.34740389 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.17238560 |
| 7 | complement activation, classical pathway (GO:0006958) | 5.95324997 |
| 8 | proline biosynthetic process (GO:0006561) | 5.51033258 |
| 9 | negative regulation of glucose transport (GO:0010829) | 5.28311887 |
| 10 | regulation of oxidative stress-induced neuron death (GO:1903203) | 4.93306046 |
| 11 | complement activation (GO:0006956) | 4.73832882 |
| 12 | respiratory burst (GO:0045730) | 4.29014460 |
| 13 | cellular response to interferon-beta (GO:0035458) | 4.28590354 |
| 14 | cellular response to type I interferon (GO:0071357) | 4.28128639 |
| 15 | type I interferon signaling pathway (GO:0060337) | 4.28128639 |
| 16 | regulation of interferon-alpha production (GO:0032647) | 4.27826701 |
| 17 | apoptotic cell clearance (GO:0043277) | 4.26649992 |
| 18 | response to type I interferon (GO:0034340) | 4.24402090 |
| 19 | positive regulation of response to oxidative stress (GO:1902884) | 4.23490611 |
| 20 | positive regulation of cellular response to oxidative stress (GO:1900409) | 4.23490611 |
| 21 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 4.22767100 |
| 22 | positive regulation of interferon-alpha production (GO:0032727) | 4.21231646 |
| 23 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.14066422 |
| 24 | cellular response to zinc ion (GO:0071294) | 4.11711182 |
| 25 | ganglioside metabolic process (GO:0001573) | 3.98410538 |
| 26 | neutrophil activation involved in immune response (GO:0002283) | 3.96797755 |
| 27 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 3.96008651 |
| 28 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 3.92224076 |
| 29 | Fc-gamma receptor signaling pathway (GO:0038094) | 3.92224076 |
| 30 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 3.92224076 |
| 31 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.92182582 |
| 32 | cellular response to exogenous dsRNA (GO:0071360) | 3.90277494 |
| 33 | cellular response to ATP (GO:0071318) | 3.88469568 |
| 34 | sialylation (GO:0097503) | 3.83001417 |
| 35 | proline metabolic process (GO:0006560) | 3.80031207 |
| 36 | protein activation cascade (GO:0072376) | 3.78120099 |
| 37 | natural killer cell differentiation (GO:0001779) | 3.75688645 |
| 38 | mitochondrial calcium ion transport (GO:0006851) | 3.71246038 |
| 39 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.66400037 |
| 40 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.62156305 |
| 41 | negative regulation of amino acid transport (GO:0051956) | 3.61500319 |
| 42 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.57845449 |
| 43 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.55160439 |
| 44 | negative regulation of B cell proliferation (GO:0030889) | 3.48932212 |
| 45 | positive regulation of immunoglobulin production (GO:0002639) | 3.47356973 |
| 46 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 3.45604157 |
| 47 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.44432909 |
| 48 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.42467988 |
| 49 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.37928241 |
| 50 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.28209035 |
| 51 | positive regulation of B cell differentiation (GO:0045579) | 3.22573309 |
| 52 | macrophage activation involved in immune response (GO:0002281) | 3.21613609 |
| 53 | I-kappaB phosphorylation (GO:0007252) | 3.20600988 |
| 54 | natural killer cell mediated immunity (GO:0002228) | 3.19438678 |
| 55 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.19438678 |
| 56 | reactive oxygen species biosynthetic process (GO:1903409) | 3.16851653 |
| 57 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.15546693 |
| 58 | glycosphingolipid biosynthetic process (GO:0006688) | 3.02739032 |
| 59 | regulation of B cell differentiation (GO:0045577) | 3.01983581 |
| 60 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.00855473 |
| 61 | negative regulation of organic acid transport (GO:0032891) | 2.99066226 |
| 62 | myeloid dendritic cell activation (GO:0001773) | 2.99022003 |
| 63 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.98449072 |
| 64 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.98449072 |
| 65 | modulation by symbiont of host immune response (GO:0052553) | 2.98449072 |
| 66 | positive regulation by symbiont of host defense response (GO:0052509) | 2.98449072 |
| 67 | modulation by symbiont of host defense response (GO:0052031) | 2.98449072 |
| 68 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.98449072 |
| 69 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.98082172 |
| 70 | angiogenesis involved in wound healing (GO:0060055) | 2.96624981 |
| 71 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.95895649 |
| 72 | superoxide anion generation (GO:0042554) | 2.95400293 |
| 73 | regulation of B cell proliferation (GO:0030888) | 2.91693531 |
| 74 | myeloid dendritic cell differentiation (GO:0043011) | 2.90673247 |
| 75 | natural killer cell activation (GO:0030101) | 2.90361506 |
| 76 | B cell receptor signaling pathway (GO:0050853) | 2.88198262 |
| 77 | humoral immune response (GO:0006959) | 2.85735243 |
| 78 | positive regulation of isotype switching (GO:0045830) | 2.85726078 |
| 79 | regulation of RIG-I signaling pathway (GO:0039535) | 2.85217696 |
| 80 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.80615983 |
| 81 | Peyers patch development (GO:0048541) | 2.80615983 |
| 82 | neutrophil activation (GO:0042119) | 2.80210842 |
| 83 | negative regulation of cellular response to insulin stimulus (GO:1900077) | 2.79228759 |
| 84 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.77522717 |
| 85 | response to peptidoglycan (GO:0032494) | 2.75119694 |
| 86 | regulation of natural killer cell activation (GO:0032814) | 2.71796734 |
| 87 | regulation of glutamate secretion (GO:0014048) | 2.71494382 |
| 88 | dendritic cell chemotaxis (GO:0002407) | 2.70943638 |
| 89 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.70586515 |
| 90 | phagocytosis (GO:0006909) | 2.69411537 |
| 91 | granulocyte activation (GO:0036230) | 2.68100074 |
| 92 | regulation of B cell activation (GO:0050864) | 2.67379287 |
| 93 | response to muramyl dipeptide (GO:0032495) | 2.67249311 |
| 94 | positive regulation of interferon-beta production (GO:0032728) | 2.65925874 |
| 95 | cellular response to interferon-gamma (GO:0071346) | 2.64837214 |
| 96 | response to interferon-beta (GO:0035456) | 2.62915715 |
| 97 | cellular response to unfolded protein (GO:0034620) | 2.62027705 |
| 98 | serine transport (GO:0032329) | 2.61459936 |
| 99 | negative regulation of glycogen biosynthetic process (GO:0045719) | 2.61100189 |
| 100 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.60293684 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.18563819 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.82996476 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.40779910 |
| 4 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.82608843 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.45265690 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.32740212 |
| 7 | GATA1_22025678_ChIP-Seq_K562_Human | 4.14604824 |
| 8 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.29021526 |
| 9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.17911689 |
| 10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.11787050 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.92504610 |
| 12 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.91916949 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.70435067 |
| 14 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.67517646 |
| 15 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.47629278 |
| 16 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.37389173 |
| 17 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.26118405 |
| 18 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.25860110 |
| 19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.08623927 |
| 20 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.07806821 |
| 21 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.85309310 |
| 22 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.83175962 |
| 23 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.78101090 |
| 24 | MYB_26560356_Chip-Seq_TH2_Human | 1.68443464 |
| 25 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.50069449 |
| 26 | RXR_22108803_ChIP-Seq_LS180_Human | 1.46296450 |
| 27 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.45845570 |
| 28 | SPI1_23127762_ChIP-Seq_K562_Human | 1.42645123 |
| 29 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.36861223 |
| 30 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.32533240 |
| 31 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.31258834 |
| 32 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.27769549 |
| 33 | MAF_26560356_Chip-Seq_TH1_Human | 1.27150957 |
| 34 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.26135369 |
| 35 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.23750180 |
| 36 | MYB_26560356_Chip-Seq_TH1_Human | 1.22746220 |
| 37 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.19641422 |
| 38 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18950495 |
| 39 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.16215238 |
| 40 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.14826955 |
| 41 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.13017719 |
| 42 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.09969842 |
| 43 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.07773192 |
| 44 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.06978914 |
| 45 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.02207930 |
| 46 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00688519 |
| 47 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.00119311 |
| 48 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.98861657 |
| 49 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.95929293 |
| 50 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.95650973 |
| 51 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93788100 |
| 52 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.91798219 |
| 53 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90849958 |
| 54 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.88489755 |
| 55 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.87107653 |
| 56 | GATA3_26560356_Chip-Seq_TH2_Human | 0.83270667 |
| 57 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.82698011 |
| 58 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.82677997 |
| 59 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.82146568 |
| 60 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.80401321 |
| 61 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.80185187 |
| 62 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.80185187 |
| 63 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.79977985 |
| 64 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.79624867 |
| 65 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.79591224 |
| 66 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.79562578 |
| 67 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.79008300 |
| 68 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.77862093 |
| 69 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.76513064 |
| 70 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73715776 |
| 71 | GATA2_19941826_ChIP-Seq_K562_Human | 0.73677323 |
| 72 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.72129502 |
| 73 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.72119961 |
| 74 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.70941839 |
| 75 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.70801272 |
| 76 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.70608279 |
| 77 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.69583143 |
| 78 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.69492291 |
| 79 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.69411402 |
| 80 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.68734564 |
| 81 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.68002341 |
| 82 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.67609759 |
| 83 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.67609759 |
| 84 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.67326541 |
| 85 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.66960760 |
| 86 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.66433227 |
| 87 | P300_19829295_ChIP-Seq_ESCs_Human | 0.66164879 |
| 88 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.65398126 |
| 89 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.65170163 |
| 90 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.64656486 |
| 91 | KDM2B_26808549_Chip-Seq_K562_Human | 0.63686604 |
| 92 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.63684636 |
| 93 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.63497399 |
| 94 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.63382566 |
| 95 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.62395897 |
| 96 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.61929853 |
| 97 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.61457690 |
| 98 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.61099429 |
| 99 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.61056014 |
| 100 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.60462584 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 6.28441079 |
| 2 | MP0005387_immune_system_phenotype | 3.90916066 |
| 3 | MP0001790_abnormal_immune_system | 3.90916066 |
| 4 | MP0001800_abnormal_humoral_immune | 3.43038495 |
| 5 | MP0003724_increased_susceptibility_to | 3.16973258 |
| 6 | MP0003303_peritoneal_inflammation | 3.13820855 |
| 7 | MP0000685_abnormal_immune_system | 2.84490359 |
| 8 | MP0008961_abnormal_basal_metabolism | 2.82765364 |
| 9 | MP0005025_abnormal_response_to | 2.81272913 |
| 10 | MP0002148_abnormal_hypersensitivity_rea | 2.80605968 |
| 11 | MP0002452_abnormal_antigen_presenting | 2.79848947 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.72531154 |
| 13 | MP0003436_decreased_susceptibility_to | 2.64772337 |
| 14 | MP0005171_absent_coat_pigmentation | 2.63437875 |
| 15 | MP0005671_abnormal_response_to | 2.61989178 |
| 16 | MP0002723_abnormal_immune_serum | 2.58861534 |
| 17 | MP0009785_altered_susceptibility_to | 2.54526395 |
| 18 | MP0004264_abnormal_extraembryonic_tissu | 2.54378613 |
| 19 | MP0006082_CNS_inflammation | 2.52441318 |
| 20 | MP0001819_abnormal_immune_cell | 2.25476110 |
| 21 | MP0002420_abnormal_adaptive_immunity | 2.22894452 |
| 22 | MP0002419_abnormal_innate_immunity | 2.21301753 |
| 23 | MP0005451_abnormal_body_composition | 2.02883155 |
| 24 | MP0010155_abnormal_intestine_physiology | 1.90086933 |
| 25 | MP0003172_abnormal_lysosome_physiology | 1.88530981 |
| 26 | MP0003195_calcinosis | 1.87051309 |
| 27 | MP0001879_abnormal_lymphatic_vessel | 1.84468361 |
| 28 | MP0003091_abnormal_cell_migration | 1.82754922 |
| 29 | MP0002398_abnormal_bone_marrow | 1.80355517 |
| 30 | MP0000716_abnormal_immune_system | 1.76145226 |
| 31 | MP0001845_abnormal_inflammatory_respons | 1.70264963 |
| 32 | MP0004233_abnormal_muscle_weight | 1.48075840 |
| 33 | MP0003075_altered_response_to | 1.45489105 |
| 34 | MP0004185_abnormal_adipocyte_glucose | 1.45080079 |
| 35 | MP0010234_abnormal_vibrissa_follicle | 1.42343311 |
| 36 | MP0005164_abnormal_response_to | 1.38283177 |
| 37 | MP0002429_abnormal_blood_cell | 1.38250553 |
| 38 | MP0003136_yellow_coat_color | 1.37735836 |
| 39 | MP0001533_abnormal_skeleton_physiology | 1.33094902 |
| 40 | MP0003690_abnormal_glial_cell | 1.25278637 |
| 41 | MP0003045_fibrosis | 1.20994202 |
| 42 | MP0000689_abnormal_spleen_morphology | 1.20683240 |
| 43 | MP0004947_skin_inflammation | 1.19679851 |
| 44 | MP0005464_abnormal_platelet_physiology | 1.18373963 |
| 45 | MP0009764_decreased_sensitivity_to | 1.16055441 |
| 46 | MP0008469_abnormal_protein_level | 1.09554513 |
| 47 | MP0004782_abnormal_surfactant_physiolog | 1.08742043 |
| 48 | MP0005076_abnormal_cell_differentiation | 1.08523091 |
| 49 | MP0004859_abnormal_synaptic_plasticity | 1.07916490 |
| 50 | MP0001905_abnormal_dopamine_level | 1.04329253 |
| 51 | MP0002876_abnormal_thyroid_physiology | 1.03284872 |
| 52 | MP0002722_abnormal_immune_system | 1.02574305 |
| 53 | MP0000013_abnormal_adipose_tissue | 1.00432743 |
| 54 | MP0003943_abnormal_hepatobiliary_system | 0.98403052 |
| 55 | MP0002102_abnormal_ear_morphology | 0.91732027 |
| 56 | MP0005377_hearing/vestibular/ear_phenot | 0.91133616 |
| 57 | MP0003878_abnormal_ear_physiology | 0.91133616 |
| 58 | MP0002638_abnormal_pupillary_reflex | 0.91071071 |
| 59 | MP0009745_abnormal_behavioral_response | 0.89872764 |
| 60 | MP0004130_abnormal_muscle_cell | 0.87436345 |
| 61 | MP0004885_abnormal_endolymph | 0.86918518 |
| 62 | MP0000858_altered_metastatic_potential | 0.86510510 |
| 63 | MP0006292_abnormal_olfactory_placode | 0.86204606 |
| 64 | MP0010307_abnormal_tumor_latency | 0.85578863 |
| 65 | MP0000372_irregular_coat_pigmentation | 0.85045506 |
| 66 | MP0002064_seizures | 0.84247197 |
| 67 | MP0003566_abnormal_cell_adhesion | 0.83823037 |
| 68 | MP0004510_myositis | 0.82220768 |
| 69 | MP0000003_abnormal_adipose_tissue | 0.81648391 |
| 70 | MP0002693_abnormal_pancreas_physiology | 0.81237486 |
| 71 | MP0000681_abnormal_thyroid_gland | 0.80734902 |
| 72 | MP0005085_abnormal_gallbladder_physiolo | 0.78958484 |
| 73 | MP0003300_gastrointestinal_ulcer | 0.78238141 |
| 74 | MP0005310_abnormal_salivary_gland | 0.77645971 |
| 75 | MP0001188_hyperpigmentation | 0.77402576 |
| 76 | MP0001881_abnormal_mammary_gland | 0.77178151 |
| 77 | MP0002277_abnormal_respiratory_mucosa | 0.74493746 |
| 78 | MP0009115_abnormal_fat_cell | 0.73226178 |
| 79 | MP0004270_analgesia | 0.70256543 |
| 80 | MP0005360_urolithiasis | 0.69681175 |
| 81 | MP0001765_abnormal_ion_homeostasis | 0.68182218 |
| 82 | MP0010386_abnormal_urinary_bladder | 0.67317603 |
| 83 | MP0002405_respiratory_system_inflammati | 0.66671609 |
| 84 | MP0005083_abnormal_biliary_tract | 0.66579423 |
| 85 | MP0000703_abnormal_thymus_morphology | 0.66160596 |
| 86 | MP0004381_abnormal_hair_follicle | 0.65745895 |
| 87 | MP0009763_increased_sensitivity_to | 0.65704654 |
| 88 | MP0004858_abnormal_nervous_system | 0.65383927 |
| 89 | MP0005174_abnormal_tail_pigmentation | 0.64167211 |
| 90 | MP0000490_abnormal_crypts_of | 0.61692387 |
| 91 | MP0003693_abnormal_embryo_hatching | 0.60935759 |
| 92 | MP0005535_abnormal_body_temperature | 0.60837266 |
| 93 | MP0002166_altered_tumor_susceptibility | 0.59405820 |
| 94 | MP0009765_abnormal_xenobiotic_induced | 0.58939113 |
| 95 | MP0003763_abnormal_thymus_physiology | 0.57306187 |
| 96 | MP0001485_abnormal_pinna_reflex | 0.56865455 |
| 97 | MP0008569_lethality_at_weaning | 0.56379889 |
| 98 | MP0002136_abnormal_kidney_physiology | 0.55929119 |
| 99 | MP0003633_abnormal_nervous_system | 0.55737887 |
| 100 | MP0003448_altered_tumor_morphology | 0.55623279 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of B cell number (HP:0010975) | 7.70636177 |
| 2 | B lymphocytopenia (HP:0010976) | 7.70636177 |
| 3 | Agammaglobulinemia (HP:0004432) | 6.60833040 |
| 4 | Recurrent bronchitis (HP:0002837) | 5.40585159 |
| 5 | Cellulitis (HP:0100658) | 5.29789433 |
| 6 | Recurrent viral infections (HP:0004429) | 5.09404579 |
| 7 | Colitis (HP:0002583) | 5.08226184 |
| 8 | Eczematoid dermatitis (HP:0000976) | 4.99995801 |
| 9 | Recurrent pneumonia (HP:0006532) | 4.69544129 |
| 10 | Chronic otitis media (HP:0000389) | 4.55511220 |
| 11 | Recurrent bacterial skin infections (HP:0005406) | 4.35001031 |
| 12 | Recurrent abscess formation (HP:0002722) | 4.20967245 |
| 13 | Meningitis (HP:0001287) | 4.10059518 |
| 14 | Alveolar cell carcinoma (HP:0006519) | 4.05410742 |
| 15 | Inflammation of the large intestine (HP:0002037) | 4.02699969 |
| 16 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.99456588 |
| 17 | Recurrent sinusitis (HP:0011108) | 3.97885080 |
| 18 | Gastrointestinal inflammation (HP:0004386) | 3.90767129 |
| 19 | Verrucae (HP:0200043) | 3.85042994 |
| 20 | Papilloma (HP:0012740) | 3.85042994 |
| 21 | Recurrent lower respiratory tract infections (HP:0002783) | 3.85000795 |
| 22 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.76949457 |
| 23 | Mediastinal lymphadenopathy (HP:0100721) | 3.74116553 |
| 24 | Increased IgM level (HP:0003496) | 3.71683164 |
| 25 | Neoplasm of the tracheobronchial system (HP:0100552) | 3.70884153 |
| 26 | Nasal polyposis (HP:0100582) | 3.54957804 |
| 27 | Autoimmune hemolytic anemia (HP:0001890) | 3.47108335 |
| 28 | Disinhibition (HP:0000734) | 3.44918572 |
| 29 | Myositis (HP:0100614) | 3.33849005 |
| 30 | Chronic sinusitis (HP:0011109) | 3.19579637 |
| 31 | Joint hemorrhage (HP:0005261) | 3.17266828 |
| 32 | Osteomyelitis (HP:0002754) | 3.10962597 |
| 33 | Gingival bleeding (HP:0000225) | 3.05090220 |
| 34 | Interstitial pulmonary disease (HP:0006530) | 3.04723069 |
| 35 | Bronchitis (HP:0012387) | 3.02274803 |
| 36 | Recurrent skin infections (HP:0001581) | 2.91024143 |
| 37 | Easy fatigability (HP:0003388) | 2.90236469 |
| 38 | Abnormality of the nasal mucosa (HP:0000433) | 2.87516527 |
| 39 | Gastrointestinal stroma tumor (HP:0100723) | 2.86152067 |
| 40 | Abnormality of macrophages (HP:0004311) | 2.75965904 |
| 41 | Pustule (HP:0200039) | 2.74448163 |
| 42 | Focal motor seizures (HP:0011153) | 2.74368491 |
| 43 | Recurrent fungal infections (HP:0002841) | 2.71873709 |
| 44 | Exercise-induced myalgia (HP:0003738) | 2.69932393 |
| 45 | Panhypogammaglobulinemia (HP:0003139) | 2.67673590 |
| 46 | Mutism (HP:0002300) | 2.67440696 |
| 47 | Pulmonary infiltrates (HP:0002113) | 2.56961749 |
| 48 | Abnormality of the common coagulation pathway (HP:0010990) | 2.52253583 |
| 49 | Vasculitis (HP:0002633) | 2.51705256 |
| 50 | Inappropriate behavior (HP:0000719) | 2.47012170 |
| 51 | Menorrhagia (HP:0000132) | 2.45711675 |
| 52 | IgM deficiency (HP:0002850) | 2.45687405 |
| 53 | Sepsis (HP:0100806) | 2.39678639 |
| 54 | Hypergammaglobulinemia (HP:0010702) | 2.37702394 |
| 55 | Basal ganglia calcification (HP:0002135) | 2.37100073 |
| 56 | Chronic obstructive pulmonary disease (HP:0006510) | 2.34152699 |
| 57 | Obstructive lung disease (HP:0006536) | 2.34152699 |
| 58 | Toxemia of pregnancy (HP:0100603) | 2.29174515 |
| 59 | IgG deficiency (HP:0004315) | 2.29099110 |
| 60 | Urticaria (HP:0001025) | 2.28455263 |
| 61 | Axonal loss (HP:0003447) | 2.22366442 |
| 62 | Gingivitis (HP:0000230) | 2.20988911 |
| 63 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.20831937 |
| 64 | Stomatitis (HP:0010280) | 2.19934321 |
| 65 | Epistaxis (HP:0000421) | 2.16413048 |
| 66 | Decreased muscle mass (HP:0003199) | 2.15453007 |
| 67 | Lower limb hyperreflexia (HP:0002395) | 2.14614733 |
| 68 | Orchitis (HP:0100796) | 2.14022484 |
| 69 | Thyroiditis (HP:0100646) | 2.07643831 |
| 70 | Large earlobe (HP:0009748) | 2.07621156 |
| 71 | Plagiocephaly (HP:0001357) | 2.04740292 |
| 72 | Abnormality of T cell physiology (HP:0011840) | 2.04044790 |
| 73 | Nonprogressive disorder (HP:0003680) | 2.03401811 |
| 74 | Emphysema (HP:0002097) | 2.02532021 |
| 75 | Apathy (HP:0000741) | 2.02420555 |
| 76 | Parakeratosis (HP:0001036) | 1.98837550 |
| 77 | Porencephaly (HP:0002132) | 1.98524615 |
| 78 | Arterial thrombosis (HP:0004420) | 1.98364017 |
| 79 | Skin rash (HP:0000988) | 1.98102050 |
| 80 | Prolonged partial thromboplastin time (HP:0003645) | 1.97686029 |
| 81 | Diminished motivation (HP:0000745) | 1.97427092 |
| 82 | T lymphocytopenia (HP:0005403) | 1.94374458 |
| 83 | Abnormality of T cell number (HP:0011839) | 1.93917277 |
| 84 | Increased cerebral lipofuscin (HP:0011813) | 1.93731624 |
| 85 | Neutropenia (HP:0001875) | 1.93639114 |
| 86 | Bronchiectasis (HP:0002110) | 1.93244614 |
| 87 | Vacuolated lymphocytes (HP:0001922) | 1.93033681 |
| 88 | Agitation (HP:0000713) | 1.89732691 |
| 89 | Abnormality of T cells (HP:0002843) | 1.89457099 |
| 90 | Oligomenorrhea (HP:0000876) | 1.88281894 |
| 91 | Retrobulbar optic neuritis (HP:0100654) | 1.86232437 |
| 92 | Optic neuritis (HP:0100653) | 1.86232437 |
| 93 | Skin ulcer (HP:0200042) | 1.85827526 |
| 94 | Conical tooth (HP:0000698) | 1.84689331 |
| 95 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.83029216 |
| 96 | IgA deficiency (HP:0002720) | 1.78623842 |
| 97 | Viral hepatitis (HP:0006562) | 1.77963196 |
| 98 | Stomach cancer (HP:0012126) | 1.77919623 |
| 99 | Acrocyanosis (HP:0001063) | 1.75865992 |
| 100 | Progressive inability to walk (HP:0002505) | 1.75236443 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 5.76205922 |
| 2 | BMPR2 | 5.63674981 |
| 3 | TNIK | 4.56214126 |
| 4 | MAP3K13 | 3.41326577 |
| 5 | MAP3K14 | 3.40694502 |
| 6 | TBK1 | 3.07907869 |
| 7 | NME2 | 2.96911058 |
| 8 | NEK9 | 2.83139540 |
| 9 | JAK3 | 2.47842224 |
| 10 | MAP3K12 | 2.26561577 |
| 11 | IKBKB | 2.24145219 |
| 12 | TYK2 | 1.94410600 |
| 13 | EIF2AK3 | 1.88920817 |
| 14 | IKBKE | 1.87431139 |
| 15 | IRAK4 | 1.79211177 |
| 16 | RIPK4 | 1.76222909 |
| 17 | DMPK | 1.75490541 |
| 18 | TAOK3 | 1.57977090 |
| 19 | MAP3K10 | 1.55269230 |
| 20 | EPHA3 | 1.52046793 |
| 21 | MAP3K9 | 1.42754490 |
| 22 | MAP3K5 | 1.42312919 |
| 23 | FLT3 | 1.41288725 |
| 24 | SYK | 1.36523675 |
| 25 | NTRK3 | 1.19943496 |
| 26 | GRK6 | 1.17820334 |
| 27 | NTRK1 | 1.13009437 |
| 28 | HCK | 1.12283989 |
| 29 | ARAF | 1.03125557 |
| 30 | BMX | 1.02596243 |
| 31 | ITK | 0.99112085 |
| 32 | MATK | 0.97202934 |
| 33 | HIPK2 | 0.92914840 |
| 34 | MARK2 | 0.92472610 |
| 35 | MST1R | 0.90092010 |
| 36 | BTK | 0.86584704 |
| 37 | EIF2AK2 | 0.86077756 |
| 38 | IRAK2 | 0.82701646 |
| 39 | JAK1 | 0.80602512 |
| 40 | ABL2 | 0.80070655 |
| 41 | CDK9 | 0.78834767 |
| 42 | GSK3A | 0.73902827 |
| 43 | IRAK1 | 0.71140678 |
| 44 | FES | 0.68827457 |
| 45 | IRAK3 | 0.67289643 |
| 46 | PBK | 0.66941141 |
| 47 | NLK | 0.66850937 |
| 48 | LYN | 0.64813623 |
| 49 | MET | 0.63069647 |
| 50 | KIT | 0.62489887 |
| 51 | PRPF4B | 0.59051488 |
| 52 | LCK | 0.58879611 |
| 53 | PLK2 | 0.56983313 |
| 54 | CSK | 0.56612086 |
| 55 | FGFR4 | 0.55783755 |
| 56 | PIK3CA | 0.55133818 |
| 57 | MAP3K11 | 0.53702282 |
| 58 | MAP2K7 | 0.52002468 |
| 59 | MAP2K4 | 0.51802361 |
| 60 | FGFR3 | 0.51659105 |
| 61 | TEC | 0.51513325 |
| 62 | EPHB1 | 0.50814955 |
| 63 | PRKCQ | 0.50729260 |
| 64 | INSR | 0.48025548 |
| 65 | SGK3 | 0.47564783 |
| 66 | DAPK1 | 0.46134825 |
| 67 | MAPK3 | 0.44519991 |
| 68 | ABL1 | 0.43194727 |
| 69 | TLK1 | 0.41430172 |
| 70 | CSF1R | 0.37717255 |
| 71 | CHUK | 0.36318450 |
| 72 | MAPK15 | 0.35833969 |
| 73 | SIK2 | 0.35042757 |
| 74 | CSNK1A1 | 0.33685582 |
| 75 | IGF1R | 0.33310378 |
| 76 | PDK1 | 0.32568982 |
| 77 | PDGFRB | 0.32565600 |
| 78 | MAPK11 | 0.30235897 |
| 79 | ALK | 0.30076222 |
| 80 | SCYL2 | 0.29631597 |
| 81 | MARK3 | 0.28056039 |
| 82 | PRKG2 | 0.26789956 |
| 83 | BLK | 0.26305753 |
| 84 | PKN1 | 0.25734325 |
| 85 | STK4 | 0.25597728 |
| 86 | DYRK3 | 0.25131579 |
| 87 | MST4 | 0.24778542 |
| 88 | NEK6 | 0.24655380 |
| 89 | MAPKAPK3 | 0.24647221 |
| 90 | ZAK | 0.23970890 |
| 91 | MAPK4 | 0.23786668 |
| 92 | ICK | 0.23741555 |
| 93 | NUAK1 | 0.21809708 |
| 94 | PRKAA2 | 0.21441137 |
| 95 | CLK1 | 0.21409527 |
| 96 | EGFR | 0.21124675 |
| 97 | FYN | 0.20557272 |
| 98 | PRKD1 | 0.20145021 |
| 99 | MAPK10 | 0.20085332 |
| 100 | RPS6KA4 | 0.20079073 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 4.14207326 |
| 2 | Protein export_Homo sapiens_hsa03060 | 3.95144822 |
| 3 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.85176219 |
| 4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.72700519 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.38331988 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.35831106 |
| 7 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.32582806 |
| 8 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.31474425 |
| 9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.20939779 |
| 10 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.19624930 |
| 11 | Malaria_Homo sapiens_hsa05144 | 2.09450569 |
| 12 | Leishmaniasis_Homo sapiens_hsa05140 | 2.07056151 |
| 13 | Asthma_Homo sapiens_hsa05310 | 2.05346915 |
| 14 | African trypanosomiasis_Homo sapiens_hsa05143 | 2.00645438 |
| 15 | Other glycan degradation_Homo sapiens_hsa00511 | 1.97175404 |
| 16 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.92171093 |
| 17 | Measles_Homo sapiens_hsa05162 | 1.82470760 |
| 18 | Allograft rejection_Homo sapiens_hsa05330 | 1.80859650 |
| 19 | Pertussis_Homo sapiens_hsa05133 | 1.69390755 |
| 20 | Influenza A_Homo sapiens_hsa05164 | 1.62910979 |
| 21 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.62899716 |
| 22 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.62762919 |
| 23 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.58122834 |
| 24 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.57332679 |
| 25 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.39389166 |
| 26 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.37442936 |
| 27 | Viral myocarditis_Homo sapiens_hsa05416 | 1.35103895 |
| 28 | Legionellosis_Homo sapiens_hsa05134 | 1.34770431 |
| 29 | Tuberculosis_Homo sapiens_hsa05152 | 1.33639822 |
| 30 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.29100803 |
| 31 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.28846568 |
| 32 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.28585340 |
| 33 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.17625636 |
| 34 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.16958953 |
| 35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.14461418 |
| 36 | Hepatitis C_Homo sapiens_hsa05160 | 1.06563040 |
| 37 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.03531317 |
| 38 | Apoptosis_Homo sapiens_hsa04210 | 1.02587309 |
| 39 | Hepatitis B_Homo sapiens_hsa05161 | 1.02296503 |
| 40 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.00647874 |
| 41 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.00051701 |
| 42 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.95024549 |
| 43 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.94663726 |
| 44 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.93590126 |
| 45 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.92732548 |
| 46 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.90581596 |
| 47 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.82651380 |
| 48 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.80965609 |
| 49 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.79040073 |
| 50 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.75801831 |
| 51 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.75175622 |
| 52 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.75125943 |
| 53 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.74688005 |
| 54 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.73446648 |
| 55 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.72779683 |
| 56 | Morphine addiction_Homo sapiens_hsa05032 | 0.70808489 |
| 57 | Circadian entrainment_Homo sapiens_hsa04713 | 0.69653188 |
| 58 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.66944757 |
| 59 | GABAergic synapse_Homo sapiens_hsa04727 | 0.66513520 |
| 60 | Platelet activation_Homo sapiens_hsa04611 | 0.63522342 |
| 61 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.60225885 |
| 62 | Long-term potentiation_Homo sapiens_hsa04720 | 0.59404080 |
| 63 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.59217275 |
| 64 | Phagosome_Homo sapiens_hsa04145 | 0.59072947 |
| 65 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.58831518 |
| 66 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.57621946 |
| 67 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.56977201 |
| 68 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.56016235 |
| 69 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.52076144 |
| 70 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.51496353 |
| 71 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.51013103 |
| 72 | Shigellosis_Homo sapiens_hsa05131 | 0.49973109 |
| 73 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.49162992 |
| 74 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.49094972 |
| 75 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.48632319 |
| 76 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.47944243 |
| 77 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.47401861 |
| 78 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.46345870 |
| 79 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.46188647 |
| 80 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.43465384 |
| 81 | Histidine metabolism_Homo sapiens_hsa00340 | 0.43220543 |
| 82 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.43131855 |
| 83 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.42070625 |
| 84 | Nicotine addiction_Homo sapiens_hsa05033 | 0.40644094 |
| 85 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.40385920 |
| 86 | Cocaine addiction_Homo sapiens_hsa05030 | 0.39231670 |
| 87 | Lysosome_Homo sapiens_hsa04142 | 0.38709087 |
| 88 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.38185446 |
| 89 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.38123274 |
| 90 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.36297614 |
| 91 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.34080588 |
| 92 | Salmonella infection_Homo sapiens_hsa05132 | 0.32894969 |
| 93 | Long-term depression_Homo sapiens_hsa04730 | 0.30930421 |
| 94 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.30094623 |
| 95 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.29833500 |
| 96 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.29485499 |
| 97 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.28631704 |
| 98 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.25252971 |
| 99 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.24366822 |
| 100 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.24092158 |

